NEWS

Next-Generation everlinQ™ 4 endoAVF System Recieves CE Mark

September 27, 2017 - everlinQ™ 4 endoAVF System has received CE Mark in the European Union. The technology uses a 4 French catheter system with enhanced visual indicators to create hemodialysis access using an endovascular technique without open surgery.  Read more

NEAT Study Published in Prominent Journal Supports Use of Innovative Endovascular Hemodialysis Access Technology

June 15, 2017 - The 12-month data published online in the American Journal of Kidney Diseases (AJKD), the official journal of the National Kidney Foundation, demonstrate the potential benefit of the novel approach to create hemodialysis access as an alternative to traditional open surgery. Read more

Comparison of Interventions Between endoAVF and a Matched Surgical AVF Cohort Published in The Journal of Vascular Access

March 25, 2017 - The Novel Endovascular Access Trial (NEAT) data was compared to a propensity-score matched surgical AVF cohort using a 5% Medicare sample.  The comparison demonstrated that patients with an endoAVF experienced fewer post-creation procedures and associated costs within the first year after fistula creation.  Read more

Exciting Clinicial Results Presented on Endovascular Hemodialysis Access Technology at LINC 2017

January 26, 2017 - Data from everlinQ™ endoAVF System: 12-month results, real-world experience, next-generation catheter, and new application for peripheral artery disease all released at LINC 2017.  Read more

TVA Medical Receives $7M in Debt Financing from Square 1 Bank

December 14, 2016 - Square 1 Bank, a division of Pacific Western Bank, today announced that it has provided a $7 million credit facility to new client TVA Medical, Inc.  Read more

TVA Medical Receives Additional Reimbursement In Germany

February 5, 2016 - TVA Medical, Inc., announced that its everlinQ™ endoAVF System has received NUB Status 1 approval in Germany.  Read more

Hemodialysis Access System Demonstrates High Suitability For Dialysis

January 28, 2016 - TVA Medical, Inc., announced primary endpoint data evaluating the everlinQ™ endoAVF System.  Read more

Early Study Results Presented for Hemodialysis Access System

November 20, 2015 - TVA Medical, Inc., announced clinical trial results from a study evaluating the everlinQ™ endoAVF System.  Read more

TVA Medical Closes $15 Million Series C Financing

October 6, 2015 - TVA Medical, Inc., today announced the completion of a $15 million Series C financing.  Read more

FLEX Study Results Published

March 25, 2015 - New Minimally Invasive Vascular Access System Demonstrates Positive Outcomes In Dialysis Patients.  Read more

TVA Medical Wins ICI Innovation Award

January 19, 2015 - Austin, Texas — TVA Medical, Inc., today announced it has won the 2014 Innovations in Cardiovascular Interventions (ICI) Best Start-Up Innovation Award. Read more

TVA’s FLEX System Demonstrates Success in Clinical Study

September 26, 2013 - Preliminary data presented last week at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting demonstrated. Read more

TVA Receives $9.5M Series B Financing

June 10, 2013 - TVA Medical, Inc. (TVA Medical), a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD), announced today. Read more

TVA Receives $2.6M Series A Financing

January 11, 2010 - Austin-based biomed startup TVA Medical Inc. wrangled $2.6 million Series A funding to spur its minimally-invasive Renal Disease treatment. Read more